Literature DB >> 21789026

Rhabdomyolysis from erlotinib: a case report.

Luca Moscetti, Fabrizio Nelli, Enzo Maria Ruggeri.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21789026     DOI: 10.1177/030089161109700327

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


× No keyword cloud information.
  4 in total

1.  Arsenic trioxide induced rhabdomyolysis, a rare but severe side effect, in an APL patient: a case report.

Authors:  Haiyan He; Ran An; Jian Hou; Weijun Fu
Journal:  Front Med       Date:  2017-04-19       Impact factor: 4.592

2.  An unexpected and devastating adverse event of dasatinib: Rhabdomyolysis.

Authors:  Burak Uz; Ilhan Dolasik
Journal:  Leuk Res Rep       Date:  2015-12-03

3.  Dasatinib-Induced Rhabdomyolysis in a 33-Year-Old Patient with Chronic Myeloid Leukemia.

Authors:  Andrew Stevenson Joel Chandranesan; Samip Master; Olivia Antosz; Breanne PeytonThomas; Nebu Koshy
Journal:  Case Rep Hematol       Date:  2018-05-06

Review 4.  Drug induced rhabdomyolysis.

Authors:  Martin Hohenegger
Journal:  Curr Opin Pharmacol       Date:  2012-05-05       Impact factor: 5.547

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.